| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial
|
Boyle, Michael P
|
|
2014
|
2 |
7 |
p. 527-538
12 p.
|
artikel
|
| 2 |
2014 American Thoracic Society International Conference
|
Kang, Seema
|
|
2014
|
2 |
7 |
p. 518-520
3 p.
|
artikel
|
| 3 |
Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial
|
Kerem, Eitan
|
|
2014
|
2 |
7 |
p. 539-547
9 p.
|
artikel
|
| 4 |
Chronic thromboembolic pulmonary hypertension
|
Hoeper, Marius M
|
|
2014
|
2 |
7 |
p. 573-582
10 p.
|
artikel
|
| 5 |
Corrections
|
|
|
2014
|
2 |
7 |
p. e12-
1 p.
|
artikel
|
| 6 |
Effect of telomere length on survival in patients with idiopathic pulmonary fibrosis: an observational cohort study with independent validation
|
Stuart, Bridget D
|
|
2014
|
2 |
7 |
p. 557-565
9 p.
|
artikel
|
| 7 |
HIV-associated obstructive lung diseases: insights and implications for the clinician
|
Drummond, M Bradley
|
|
2014
|
2 |
7 |
p. 583-592
10 p.
|
artikel
|
| 8 |
Idiopathic pulmonary fibrosis in the USA
|
Myllärniemi, Marjukka
|
|
2014
|
2 |
7 |
p. 515-516
2 p.
|
artikel
|
| 9 |
Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001–11
|
Raghu, Ganesh
|
|
2014
|
2 |
7 |
p. 566-572
7 p.
|
artikel
|
| 10 |
Japan: in the wake of the 2011 tsunami
|
McCurry, Justin
|
|
2014
|
2 |
7 |
p. 521-522
2 p.
|
artikel
|
| 11 |
Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study
|
Han, MeiLan K
|
|
2014
|
2 |
7 |
p. 548-556
9 p.
|
artikel
|
| 12 |
Philip Drinker
|
Akkermans, Rebecca
|
|
2014
|
2 |
7 |
p. 525-526
2 p.
|
artikel
|
| 13 |
Project Breathe Easy
|
Spencer, Kate
|
|
2014
|
2 |
7 |
p. 526-
1 p.
|
artikel
|
| 14 |
Reducing complications from obstructive sleep apnoea
|
Gilbert, Judith A
|
|
2014
|
2 |
7 |
p. 517-
1 p.
|
artikel
|
| 15 |
Respiratory microbiome in IPF: cause, effect, or biomarker?
|
Molyneaux, Philip L
|
|
2014
|
2 |
7 |
p. 511-513
3 p.
|
artikel
|
| 16 |
Short telomeres: a repeat offender in IPF
|
Stanley, Susan E
|
|
2014
|
2 |
7 |
p. 513-514
2 p.
|
artikel
|
| 17 |
Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortality
|
Leonardi-Bee, Jo
|
|
2014
|
2 |
7 |
p. e10-e12
nvt p.
|
artikel
|
| 18 |
Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortality
|
Wolkewitz, Martin
|
|
2014
|
2 |
7 |
p. e8-e9
nvt p.
|
artikel
|
| 19 |
Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortality
|
Antes, Gerd
|
|
2014
|
2 |
7 |
p. e10-
1 p.
|
artikel
|
| 20 |
Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortality
|
Jones, Mark
|
|
2014
|
2 |
7 |
p. e9-e10
nvt p.
|
artikel
|
| 21 |
Targeting nonsense-mediated cystic fibrosis: is it premature to stop now?
|
O'Sullivan, Brian P
|
|
2014
|
2 |
7 |
p. 509-511
3 p.
|
artikel
|
| 22 |
The changing landscape of idiopathic pulmonary fibrosis
|
The Lancet Respiratory Medicine,
|
|
2014
|
2 |
7 |
p. 507-
1 p.
|
artikel
|
| 23 |
The fog of war
|
Burki, Talha Khan
|
|
2014
|
2 |
7 |
p. 523-524
2 p.
|
artikel
|
| 24 |
The stony road to phe508del CFTR pharmacotherapy: smoothing the first rock
|
Tümmler, Burkhard
|
|
2014
|
2 |
7 |
p. 508-509
2 p.
|
artikel
|
| 25 |
Third-generation EGFR-TKIs—a new hope for NSCLC
|
Akkermans, Rebecca
|
|
2014
|
2 |
7 |
p. 520-
1 p.
|
artikel
|
Tijdschrift beschrijving